• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEPHA, INC. - 3005670760 GALAFLEX 3DR; BREAST - ABSORBABLE MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEPHA, INC. - 3005670760 GALAFLEX 3DR; BREAST - ABSORBABLE MESH Back to Search Results
Model Number 100043-03
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Pain (1994)
Date of Event 03/19/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No conclusions can be made.The patient's attorney alleges pain and injury associated with the galaflex 3dr used to treat the patient.The patient's attorney alleges that the patient had subsequent surgical intervention during which the galaflex 3dr implant was removed; however, no details have been provided.A review of manufacturing records was conducted and shows the product was manufactured to specification.Should additional information be provided, a supplemental emdr will be submitted.Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
Per information provided: attorney alleges that the patient underwent breast reconstruction revision surgery on (b)(6) 2021, during which a galaflex 3dr was implanted.On (b)(6) 2026, the galaflex mesh was surgically excised due to the reported pain and injury.Patient was injured severely and permanently.As alleged, the patient experienced surgical intervention, mental anguish and pain.Attorney alleges general allegations for "past, present, and future damages, including but not limited to, mental and physical pain and suffering for severe and permanent personal injuries sustained by the patient." it is also alleged that the device was defective.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GALAFLEX 3DR
Common Device Name
BREAST - ABSORBABLE MESH
Manufacturer (Section D)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer (Section G)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key25376214
Report Number1213643-2026-00708
Device Sequence Number21131362
Product Code OOD
UDI-Device Identifier00810054980025
UDI-Public(01)00810054980025(17)250525(10)210478
Combination Product (Y/N)N
Initial Reporter StateRI
Initial Reporter CountryUS
PMA/510(K) Number
K162922
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 06/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/25/2025
Device Model Number100043-03
Device Catalogue NumberFR3D03
Device Lot Number210478
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/13/2026
Supplement Date Received by Manufacturer06/29/2026
Initial Report FDA Received Date06/03/2026
Supplement Report FDA Received Date07/14/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/20/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age48 YR
Patient SexFemale
-
-